Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 41 | 2024 | 3804 | 7.330 |
Why?
|
Kruppel-Like Transcription Factors | 18 | 2022 | 507 | 3.800 |
Why?
|
Atherosclerosis | 20 | 2024 | 3433 | 3.520 |
Why?
|
Endothelial Cells | 27 | 2023 | 3589 | 3.500 |
Why?
|
Early Growth Response Transcription Factors | 7 | 2022 | 32 | 2.890 |
Why?
|
Neovascularization, Physiologic | 11 | 2024 | 1369 | 2.450 |
Why?
|
Peripheral Arterial Disease | 13 | 2024 | 1304 | 2.220 |
Why?
|
Plaque, Atherosclerotic | 8 | 2024 | 1551 | 1.620 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2023 | 1125 | 1.530 |
Why?
|
Ischemia | 9 | 2024 | 1901 | 1.500 |
Why?
|
Vascular System Injuries | 3 | 2020 | 248 | 1.440 |
Why?
|
MAP Kinase Signaling System | 3 | 2022 | 1492 | 1.330 |
Why?
|
Signal Transduction | 36 | 2024 | 23640 | 1.300 |
Why?
|
Arteries | 3 | 2020 | 1127 | 1.220 |
Why?
|
RNA, Untranslated | 3 | 2021 | 455 | 1.220 |
Why?
|
Myocytes, Smooth Muscle | 8 | 2022 | 703 | 1.200 |
Why?
|
Vasculitis | 5 | 2020 | 526 | 1.180 |
Why?
|
Macrophages | 17 | 2024 | 5798 | 1.180 |
Why?
|
Receptors, LDL | 4 | 2024 | 493 | 1.130 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2020 | 694 | 1.070 |
Why?
|
Diabetic Cardiomyopathies | 2 | 2017 | 91 | 1.010 |
Why?
|
Animals | 89 | 2024 | 169225 | 1.010 |
Why?
|
Cardiovascular Diseases | 10 | 2024 | 15662 | 1.010 |
Why?
|
NF-kappa B | 9 | 2022 | 2493 | 1.010 |
Why?
|
Transforming Growth Factor beta | 10 | 2023 | 1995 | 1.000 |
Why?
|
Neovascularization, Pathologic | 6 | 2021 | 2630 | 1.000 |
Why?
|
Smad1 Protein | 2 | 2016 | 81 | 0.940 |
Why?
|
Diabetic Angiopathies | 3 | 2024 | 806 | 0.940 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2022 | 3116 | 0.930 |
Why?
|
Mice | 57 | 2024 | 82024 | 0.910 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5887 | 0.910 |
Why?
|
Succinic Acid | 1 | 2024 | 86 | 0.910 |
Why?
|
Muscle, Smooth, Vascular | 8 | 2022 | 1495 | 0.890 |
Why?
|
Wound Healing | 3 | 2020 | 2801 | 0.890 |
Why?
|
Aortic Diseases | 3 | 2024 | 741 | 0.850 |
Why?
|
Mice, Inbred C57BL | 18 | 2024 | 22381 | 0.850 |
Why?
|
Gene Expression Regulation | 23 | 2024 | 11930 | 0.850 |
Why?
|
Endothelium, Vascular | 9 | 2022 | 4427 | 0.820 |
Why?
|
Mice, Knockout | 14 | 2024 | 14484 | 0.820 |
Why?
|
Carotid Artery Diseases | 2 | 2021 | 879 | 0.810 |
Why?
|
Serum Response Factor | 2 | 2021 | 78 | 0.760 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 644 | 0.750 |
Why?
|
MAP Kinase Kinase Kinase 4 | 1 | 2020 | 3 | 0.740 |
Why?
|
Tunica Intima | 4 | 2022 | 459 | 0.730 |
Why?
|
Inflammation | 14 | 2022 | 10872 | 0.700 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2020 | 111 | 0.670 |
Why?
|
Antirheumatic Agents | 4 | 2023 | 1381 | 0.660 |
Why?
|
Methotrexate | 4 | 2023 | 1721 | 0.630 |
Why?
|
Monocytes | 9 | 2017 | 2604 | 0.620 |
Why?
|
Oligonucleotides, Antisense | 3 | 2020 | 462 | 0.620 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18345 | 0.610 |
Why?
|
Bone Marrow Cells | 5 | 2013 | 2415 | 0.610 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2022 | 4415 | 0.590 |
Why?
|
Snow | 1 | 2017 | 15 | 0.580 |
Why?
|
RNA, Small Nucleolar | 1 | 2017 | 27 | 0.580 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2024 | 1247 | 0.560 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2016 | 317 | 0.560 |
Why?
|
Insulin Resistance | 4 | 2021 | 3986 | 0.550 |
Why?
|
Cell Proliferation | 11 | 2022 | 10471 | 0.550 |
Why?
|
Interferons | 1 | 2020 | 720 | 0.540 |
Why?
|
Genome, Viral | 1 | 2020 | 674 | 0.540 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2019 | 706 | 0.540 |
Why?
|
Transforming Growth Factor beta1 | 6 | 2011 | 638 | 0.530 |
Why?
|
Myeloid Progenitor Cells | 3 | 2011 | 112 | 0.520 |
Why?
|
Tamoxifen | 1 | 2020 | 966 | 0.520 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2889 | 0.520 |
Why?
|
Oxidative Stress | 2 | 2020 | 3140 | 0.510 |
Why?
|
Adenosine | 1 | 2021 | 820 | 0.510 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2020 | 1244 | 0.510 |
Why?
|
Aorta | 6 | 2022 | 2045 | 0.500 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1027 | 0.500 |
Why?
|
Adaptive Immunity | 1 | 2020 | 733 | 0.500 |
Why?
|
Gene Expression Profiling | 4 | 2022 | 9536 | 0.490 |
Why?
|
Phosphofructokinase-2 | 1 | 2015 | 33 | 0.480 |
Why?
|
Granulocyte-Macrophage Progenitor Cells | 2 | 2011 | 21 | 0.480 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2016 | 165 | 0.480 |
Why?
|
Myocardial Infarction | 8 | 2024 | 11519 | 0.480 |
Why?
|
N-Ethylmaleimide-Sensitive Proteins | 1 | 2014 | 9 | 0.480 |
Why?
|
NF-kappa B p50 Subunit | 2 | 2012 | 103 | 0.470 |
Why?
|
RNA, Messenger | 9 | 2022 | 12797 | 0.460 |
Why?
|
Humans | 98 | 2024 | 767998 | 0.460 |
Why?
|
Fatty Liver | 1 | 2020 | 809 | 0.460 |
Why?
|
Immunologic Memory | 3 | 2020 | 1378 | 0.450 |
Why?
|
Cell Differentiation | 8 | 2022 | 11666 | 0.440 |
Why?
|
Thrombin | 1 | 2016 | 600 | 0.440 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 304 | 0.430 |
Why?
|
Lipoproteins, VLDL | 1 | 2014 | 201 | 0.430 |
Why?
|
Epigenesis, Genetic | 3 | 2021 | 3834 | 0.420 |
Why?
|
Adipose Tissue, White | 1 | 2016 | 371 | 0.410 |
Why?
|
Cell Nucleus | 2 | 2020 | 2881 | 0.410 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 96 | 0.410 |
Why?
|
DNA-Binding Proteins | 12 | 2011 | 9614 | 0.400 |
Why?
|
Coxsackievirus Infections | 1 | 2012 | 45 | 0.400 |
Why?
|
Blood Vessels | 1 | 2018 | 1110 | 0.400 |
Why?
|
Veins | 1 | 2016 | 769 | 0.390 |
Why?
|
Trans-Activators | 8 | 2007 | 2857 | 0.390 |
Why?
|
Coronary Restenosis | 1 | 2014 | 396 | 0.380 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3781 | 0.380 |
Why?
|
Paracrine Communication | 1 | 2013 | 278 | 0.380 |
Why?
|
Myocardial Ischemia | 2 | 2020 | 2138 | 0.380 |
Why?
|
Diabetes Complications | 1 | 2018 | 1319 | 0.380 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 12253 | 0.360 |
Why?
|
DNA Damage | 2 | 2020 | 2470 | 0.360 |
Why?
|
Cardiovascular System | 2 | 2017 | 841 | 0.360 |
Why?
|
Adipose Tissue | 4 | 2020 | 3329 | 0.350 |
Why?
|
Apolipoproteins E | 3 | 2013 | 1461 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2456 | 0.350 |
Why?
|
Transcription Factors | 10 | 2023 | 12165 | 0.350 |
Why?
|
Coronary Artery Disease | 3 | 2021 | 6569 | 0.350 |
Why?
|
Diabetic Nephropathies | 1 | 2017 | 974 | 0.340 |
Why?
|
Gene Knockdown Techniques | 3 | 2022 | 1605 | 0.340 |
Why?
|
Cell Line | 14 | 2021 | 15597 | 0.330 |
Why?
|
Mechanotransduction, Cellular | 1 | 2015 | 541 | 0.330 |
Why?
|
Myocytes, Cardiac | 5 | 2024 | 1681 | 0.330 |
Why?
|
Wounds, Nonpenetrating | 1 | 2016 | 807 | 0.320 |
Why?
|
Hydrogels | 2 | 2024 | 744 | 0.310 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 845 | 0.300 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 306 | 0.300 |
Why?
|
Obesity | 5 | 2024 | 13092 | 0.300 |
Why?
|
Drug Discovery | 2 | 2017 | 1068 | 0.290 |
Why?
|
Cytokines | 9 | 2024 | 7453 | 0.280 |
Why?
|
Cell Movement | 4 | 2021 | 5209 | 0.280 |
Why?
|
Triglycerides | 2 | 2014 | 2463 | 0.270 |
Why?
|
Ventricular Remodeling | 1 | 2014 | 1281 | 0.270 |
Why?
|
Chemotaxis | 2 | 2024 | 600 | 0.270 |
Why?
|
Vaccinia virus | 1 | 2008 | 328 | 0.260 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2014 | 2145 | 0.260 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1625 | 0.260 |
Why?
|
Male | 40 | 2024 | 364638 | 0.260 |
Why?
|
Homeostasis | 2 | 2021 | 3348 | 0.250 |
Why?
|
Leukocytes | 2 | 2012 | 2036 | 0.250 |
Why?
|
Cells, Cultured | 10 | 2024 | 19015 | 0.250 |
Why?
|
Leukocytes, Mononuclear | 3 | 2022 | 1854 | 0.250 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2824 | 0.250 |
Why?
|
Vascular Diseases | 1 | 2013 | 1162 | 0.240 |
Why?
|
Smad Proteins | 1 | 2005 | 157 | 0.240 |
Why?
|
Myocardium | 2 | 2022 | 4788 | 0.240 |
Why?
|
Stem Cells | 2 | 2020 | 3537 | 0.240 |
Why?
|
Aging | 1 | 2024 | 8745 | 0.240 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2008 | 1353 | 0.230 |
Why?
|
Myocarditis | 1 | 2012 | 802 | 0.230 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3514 | 0.230 |
Why?
|
Antigen Presentation | 2 | 2008 | 1251 | 0.230 |
Why?
|
Transcription Factor RelA | 2 | 2021 | 252 | 0.230 |
Why?
|
Smad3 Protein | 5 | 2005 | 166 | 0.220 |
Why?
|
Silk | 1 | 2024 | 93 | 0.220 |
Why?
|
Energy Metabolism | 1 | 2015 | 2908 | 0.220 |
Why?
|
Macrophage Activation | 6 | 2008 | 557 | 0.210 |
Why?
|
Gene Silencing | 3 | 2020 | 1505 | 0.210 |
Why?
|
Hindlimb | 3 | 2024 | 516 | 0.210 |
Why?
|
Transforming Growth Factors | 1 | 2022 | 76 | 0.210 |
Why?
|
Factor X | 1 | 2022 | 64 | 0.200 |
Why?
|
Regional Blood Flow | 2 | 2020 | 1498 | 0.200 |
Why?
|
Inhibins | 1 | 2023 | 210 | 0.200 |
Why?
|
Muscle, Skeletal | 5 | 2022 | 4978 | 0.200 |
Why?
|
RNA | 2 | 2022 | 2718 | 0.200 |
Why?
|
Interleukin-9 | 1 | 2022 | 62 | 0.200 |
Why?
|
Genetic Markers | 2 | 2020 | 2602 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8616 | 0.190 |
Why?
|
Arteriosclerosis | 5 | 2007 | 1055 | 0.190 |
Why?
|
RNA, Small Interfering | 4 | 2023 | 3428 | 0.190 |
Why?
|
Chemokine CCL2 | 1 | 2004 | 605 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2015 | 4648 | 0.190 |
Why?
|
Blood Glucose | 1 | 2016 | 6429 | 0.180 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2020 | 12 | 0.180 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.180 |
Why?
|
Neutrophils | 1 | 2013 | 3786 | 0.170 |
Why?
|
Phosphorylation | 4 | 2019 | 8314 | 0.170 |
Why?
|
Swine | 2 | 2020 | 6002 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 125 | 0.170 |
Why?
|
Complement Activation | 1 | 2022 | 447 | 0.170 |
Why?
|
Fibroblasts | 3 | 2016 | 4176 | 0.170 |
Why?
|
I-kappa B Kinase | 1 | 2021 | 250 | 0.170 |
Why?
|
Tumor Suppressor Proteins | 2 | 2020 | 2801 | 0.170 |
Why?
|
Promoter Regions, Genetic | 11 | 2011 | 5798 | 0.160 |
Why?
|
Metalloendopeptidases | 2 | 2000 | 386 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 547 | 0.160 |
Why?
|
Sus scrofa | 1 | 2021 | 430 | 0.160 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2019 | 22 | 0.160 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2022 | 553 | 0.160 |
Why?
|
Angiotensin II | 1 | 2022 | 842 | 0.160 |
Why?
|
Medicare | 4 | 2024 | 6814 | 0.160 |
Why?
|
Repressor Proteins | 3 | 2004 | 2982 | 0.160 |
Why?
|
Necrosis | 1 | 2023 | 1616 | 0.160 |
Why?
|
Inflammation Mediators | 3 | 2018 | 1892 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 368 | 0.150 |
Why?
|
Gene Targeting | 1 | 2021 | 841 | 0.150 |
Why?
|
Oxygen | 3 | 2024 | 4269 | 0.150 |
Why?
|
Angiogenic Proteins | 1 | 2018 | 101 | 0.150 |
Why?
|
Intermittent Claudication | 1 | 2020 | 305 | 0.150 |
Why?
|
Interleukin-10 | 2 | 2022 | 1183 | 0.150 |
Why?
|
Ebola Vaccines | 1 | 2017 | 25 | 0.150 |
Why?
|
Organ Culture Techniques | 1 | 2020 | 794 | 0.140 |
Why?
|
Retinal Diseases | 1 | 2023 | 710 | 0.140 |
Why?
|
Nitric Oxide Synthase Type II | 5 | 2007 | 514 | 0.140 |
Why?
|
Hypercholesterolemia | 2 | 2021 | 1145 | 0.140 |
Why?
|
Glucose | 3 | 2021 | 4351 | 0.140 |
Why?
|
Species Specificity | 2 | 2020 | 2414 | 0.140 |
Why?
|
Lipopolysaccharides | 5 | 2021 | 2219 | 0.140 |
Why?
|
Dendritic Cells | 1 | 2008 | 2746 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1104 | 0.140 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 874 | 0.130 |
Why?
|
Autoimmune Diseases | 2 | 2021 | 2256 | 0.130 |
Why?
|
Codon, Terminator | 1 | 2017 | 125 | 0.130 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2094 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2021 | 812 | 0.130 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 581 | 0.130 |
Why?
|
Cell Cycle Proteins | 4 | 2023 | 3443 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2023 | 4351 | 0.130 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2016 | 48 | 0.130 |
Why?
|
Viral Proteins | 2 | 2020 | 1802 | 0.130 |
Why?
|
Carotid Arteries | 2 | 2017 | 942 | 0.130 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 996 | 0.130 |
Why?
|
Arthritis | 1 | 2021 | 684 | 0.130 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 776 | 0.130 |
Why?
|
Regeneration | 1 | 2024 | 1524 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1753 | 0.120 |
Why?
|
Neoplasms | 2 | 2022 | 22369 | 0.120 |
Why?
|
Transfection | 7 | 2007 | 5757 | 0.120 |
Why?
|
Female | 22 | 2024 | 397102 | 0.120 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 149 | 0.120 |
Why?
|
Immune System | 1 | 2020 | 799 | 0.120 |
Why?
|
Ebolavirus | 1 | 2017 | 250 | 0.120 |
Why?
|
Research Personnel | 1 | 2020 | 589 | 0.120 |
Why?
|
Mice, Obese | 1 | 2016 | 417 | 0.120 |
Why?
|
American Heart Association | 1 | 2020 | 1050 | 0.120 |
Why?
|
Protein Transport | 1 | 2020 | 1951 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8637 | 0.120 |
Why?
|
Fibrosis | 1 | 2022 | 2080 | 0.120 |
Why?
|
Gene Deletion | 2 | 2017 | 2673 | 0.120 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2016 | 97 | 0.120 |
Why?
|
Immunoprecipitation | 1 | 2017 | 874 | 0.120 |
Why?
|
Dermis | 1 | 2016 | 203 | 0.120 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1837 | 0.120 |
Why?
|
T-Lymphocytes, Cytotoxic | 6 | 2001 | 1801 | 0.110 |
Why?
|
Transcription, Genetic | 8 | 2021 | 7613 | 0.110 |
Why?
|
Phenotype | 3 | 2021 | 16723 | 0.110 |
Why?
|
Peptide Fragments | 3 | 2021 | 5151 | 0.110 |
Why?
|
Estrogens | 1 | 2020 | 1536 | 0.110 |
Why?
|
Mesenchymal Stem Cells | 1 | 2024 | 1672 | 0.110 |
Why?
|
Disease Progression | 4 | 2023 | 13667 | 0.110 |
Why?
|
Gap Junctions | 1 | 2015 | 230 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1197 | 0.110 |
Why?
|
Critical Illness | 2 | 2020 | 2756 | 0.110 |
Why?
|
Receptors, CCR4 | 1 | 2013 | 77 | 0.110 |
Why?
|
Computer-Aided Design | 1 | 2015 | 291 | 0.100 |
Why?
|
Karyopherins | 1 | 2013 | 134 | 0.100 |
Why?
|
Transcription Factor AP-1 | 3 | 2006 | 322 | 0.100 |
Why?
|
Protein Kinases | 1 | 2020 | 1610 | 0.100 |
Why?
|
Models, Biological | 3 | 2020 | 9493 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2721 | 0.100 |
Why?
|
Nitric Oxide Synthase | 4 | 2004 | 911 | 0.100 |
Why?
|
alpha Karyopherins | 1 | 2012 | 42 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15944 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1751 | 0.100 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 424 | 0.100 |
Why?
|
Risk Factors | 7 | 2024 | 74938 | 0.100 |
Why?
|
E-Selectin | 2 | 2012 | 577 | 0.100 |
Why?
|
Gene Expression | 3 | 2016 | 7597 | 0.100 |
Why?
|
Culture Media, Conditioned | 1 | 2013 | 521 | 0.100 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 556 | 0.090 |
Why?
|
Lipoproteins | 1 | 2016 | 879 | 0.090 |
Why?
|
Epidemics | 1 | 2017 | 517 | 0.090 |
Why?
|
Antigens, CD34 | 1 | 2013 | 657 | 0.090 |
Why?
|
Endotoxemia | 1 | 2012 | 198 | 0.090 |
Why?
|
Blood Sedimentation | 2 | 2022 | 236 | 0.090 |
Why?
|
Structure-Activity Relationship | 2 | 2015 | 3055 | 0.090 |
Why?
|
Molecular Structure | 1 | 2015 | 1883 | 0.090 |
Why?
|
Time Factors | 9 | 2024 | 40210 | 0.090 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1904 | 0.090 |
Why?
|
Muscle Proteins | 3 | 2002 | 1165 | 0.090 |
Why?
|
Apoptosis | 3 | 2020 | 9521 | 0.080 |
Why?
|
Bone Marrow Transplantation | 2 | 2019 | 2711 | 0.080 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 693 | 0.080 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 742 | 0.080 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 3 | 2004 | 26 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2299 | 0.080 |
Why?
|
Hemodynamics | 1 | 2020 | 4194 | 0.080 |
Why?
|
T-Lymphocytes | 4 | 2008 | 10264 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3568 | 0.080 |
Why?
|
Embryonic Development | 1 | 2013 | 724 | 0.080 |
Why?
|
Mast Cells | 1 | 2016 | 1405 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2012 | 377 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2953 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 3079 | 0.080 |
Why?
|
Liver | 2 | 2021 | 7575 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 842 | 0.070 |
Why?
|
Receptors, Prostaglandin E | 1 | 2008 | 56 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1889 | 0.070 |
Why?
|
p300-CBP Transcription Factors | 2 | 2006 | 148 | 0.070 |
Why?
|
Nucleoproteins | 1 | 2008 | 110 | 0.070 |
Why?
|
Aspirin | 1 | 2019 | 3135 | 0.070 |
Why?
|
Smallpox Vaccine | 1 | 2008 | 77 | 0.070 |
Why?
|
RNA Interference | 1 | 2016 | 2830 | 0.070 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 2004 | 287 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2764 | 0.070 |
Why?
|
Coculture Techniques | 1 | 2011 | 1340 | 0.070 |
Why?
|
Hematopoietic System | 1 | 2007 | 110 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3681 | 0.070 |
Why?
|
HLA-A2 Antigen | 2 | 1998 | 207 | 0.070 |
Why?
|
Protein Binding | 4 | 2008 | 9343 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 29984 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1323 | 0.070 |
Why?
|
Interferon-gamma | 3 | 2005 | 3159 | 0.070 |
Why?
|
Receptors, CXCR3 | 1 | 2007 | 240 | 0.070 |
Why?
|
Middle Aged | 12 | 2024 | 223422 | 0.070 |
Why?
|
Chick Embryo | 1 | 2008 | 975 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2005 | 1724 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 420 | 0.060 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2001 | 545 | 0.060 |
Why?
|
Rats | 4 | 2024 | 23751 | 0.060 |
Why?
|
Blotting, Western | 2 | 2005 | 5023 | 0.060 |
Why?
|
Risk Assessment | 5 | 2024 | 24317 | 0.060 |
Why?
|
Transcriptional Activation | 3 | 2007 | 1752 | 0.060 |
Why?
|
Nitrites | 1 | 2005 | 156 | 0.060 |
Why?
|
Tyramine | 1 | 2024 | 55 | 0.060 |
Why?
|
Simian immunodeficiency virus | 2 | 2001 | 814 | 0.060 |
Why?
|
Digitalis | 1 | 2004 | 14 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59600 | 0.060 |
Why?
|
Digitoxin | 1 | 2004 | 19 | 0.060 |
Why?
|
Plant Poisoning | 1 | 2004 | 13 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2007 | 660 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5402 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10757 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1596 | 0.060 |
Why?
|
Colloids | 1 | 2024 | 125 | 0.060 |
Why?
|
Binding Sites | 2 | 2005 | 6022 | 0.060 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2005 | 279 | 0.060 |
Why?
|
Aged | 9 | 2024 | 171453 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4565 | 0.060 |
Why?
|
Gangrene | 1 | 2024 | 92 | 0.060 |
Why?
|
Matrix Metalloproteinase 12 | 2 | 2000 | 44 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 4576 | 0.060 |
Why?
|
DNA | 3 | 2007 | 7213 | 0.060 |
Why?
|
Thrombosis | 2 | 2016 | 2957 | 0.060 |
Why?
|
Blotting, Northern | 1 | 2005 | 1550 | 0.060 |
Why?
|
Cell Separation | 1 | 2009 | 1729 | 0.050 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2023 | 89 | 0.050 |
Why?
|
Up-Regulation | 3 | 2021 | 4146 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2008 | 1864 | 0.050 |
Why?
|
Gelatin | 1 | 2024 | 231 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2599 | 0.050 |
Why?
|
Genetic Testing | 1 | 2016 | 3591 | 0.050 |
Why?
|
HIV Antigens | 3 | 1998 | 328 | 0.050 |
Why?
|
Bradycardia | 1 | 2004 | 305 | 0.050 |
Why?
|
Tissue Adhesives | 1 | 2024 | 177 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2023 | 6314 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2023 | 2299 | 0.050 |
Why?
|
Chemokine CXCL12 | 1 | 2024 | 457 | 0.050 |
Why?
|
Cell Hypoxia | 1 | 2024 | 662 | 0.050 |
Why?
|
Complement Membrane Attack Complex | 1 | 2022 | 105 | 0.050 |
Why?
|
Zebrafish | 1 | 2013 | 3036 | 0.050 |
Why?
|
Ventricular Function, Left | 2 | 2013 | 3941 | 0.050 |
Why?
|
Adiponectin | 1 | 2007 | 1117 | 0.050 |
Why?
|
Biology | 1 | 2023 | 292 | 0.050 |
Why?
|
Down-Regulation | 2 | 2005 | 2936 | 0.050 |
Why?
|
RNA, Small Untranslated | 1 | 2021 | 77 | 0.050 |
Why?
|
Injections | 1 | 2024 | 840 | 0.050 |
Why?
|
Cardiotonic Agents | 1 | 2024 | 542 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2010 | 2059 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2002 | 1683 | 0.040 |
Why?
|
Anti-Obesity Agents | 1 | 2024 | 240 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2002 | 437 | 0.040 |
Why?
|
Hyperplasia | 1 | 2004 | 1151 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2013 | 2194 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2004 | 1526 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1667 | 0.040 |
Why?
|
High Mobility Group Proteins | 1 | 2001 | 179 | 0.040 |
Why?
|
Lymphocyte Activation | 3 | 2008 | 5505 | 0.040 |
Why?
|
HIV Seropositivity | 2 | 2017 | 966 | 0.040 |
Why?
|
Enzyme Induction | 1 | 2000 | 455 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 2004 | 4838 | 0.040 |
Why?
|
Integrins | 1 | 2004 | 842 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 186 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3858 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2004 | 1134 | 0.040 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5799 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15443 | 0.040 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2024 | 507 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2020 | 1168 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2021 | 453 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18069 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2009 | 5904 | 0.040 |
Why?
|
Databases, Factual | 2 | 2024 | 8082 | 0.040 |
Why?
|
HIV-1 | 4 | 1998 | 6960 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3771 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2004 | 3740 | 0.040 |
Why?
|
Antigenic Variation | 1 | 1998 | 117 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2008 | 3402 | 0.040 |
Why?
|
Cell Lineage | 1 | 2007 | 2574 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3814 | 0.040 |
Why?
|
HLA-A Antigens | 1 | 1998 | 223 | 0.040 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 1996 | 222 | 0.040 |
Why?
|
Endothelium | 1 | 2021 | 768 | 0.040 |
Why?
|
Gene Products, gag | 1 | 1998 | 318 | 0.040 |
Why?
|
Amino Acid Sequence | 8 | 2004 | 13420 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 861 | 0.040 |
Why?
|
HIV Long-Term Survivors | 1 | 1998 | 140 | 0.040 |
Why?
|
United States | 5 | 2024 | 73033 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 787 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2000 | 855 | 0.040 |
Why?
|
Vesiculovirus | 1 | 2017 | 53 | 0.040 |
Why?
|
Liberia | 1 | 2017 | 176 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2017 | 224 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2002 | 1083 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 17128 | 0.030 |
Why?
|
Molecular Sequence Data | 8 | 2004 | 17617 | 0.030 |
Why?
|
Microfilament Proteins | 2 | 2002 | 1133 | 0.030 |
Why?
|
Epitopes | 3 | 1998 | 2526 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 1999 | 537 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9556 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2023 | 944 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 361 | 0.030 |
Why?
|
P-Selectin | 1 | 1999 | 598 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2017 | 554 | 0.030 |
Why?
|
Neural Crest | 1 | 1998 | 278 | 0.030 |
Why?
|
Advisory Committees | 1 | 2020 | 797 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2020 | 697 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1820 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 22286 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1217 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 4525 | 0.030 |
Why?
|
DNA Primers | 4 | 2004 | 2827 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2227 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1613 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1999 | 1442 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2024 | 65360 | 0.030 |
Why?
|
Plasmids | 1 | 2019 | 2269 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 1998 | 931 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2022 | 4857 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3720 | 0.030 |
Why?
|
Stents | 1 | 2005 | 3195 | 0.030 |
Why?
|
Adenoviridae | 1 | 2017 | 1092 | 0.030 |
Why?
|
Walking | 1 | 2020 | 1201 | 0.030 |
Why?
|
RNA, Viral | 2 | 2017 | 2871 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2403 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1999 | 1363 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2002 | 130 | 0.020 |
Why?
|
Base Sequence | 5 | 2004 | 12417 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2022 | 3228 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4289 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 5919 | 0.020 |
Why?
|
Heart Failure | 1 | 2015 | 11884 | 0.020 |
Why?
|
Cercocebus atys | 2 | 2001 | 12 | 0.020 |
Why?
|
Electrocardiography | 2 | 2004 | 6411 | 0.020 |
Why?
|
3T3 Cells | 2 | 2002 | 1084 | 0.020 |
Why?
|
Stress, Mechanical | 2 | 2007 | 1676 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2230 | 0.020 |
Why?
|
Communicable Disease Control | 1 | 2017 | 857 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2004 | 3305 | 0.020 |
Why?
|
Fever | 1 | 2017 | 1613 | 0.020 |
Why?
|
Age Factors | 2 | 2024 | 18405 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4857 | 0.020 |
Why?
|
DNA Repair | 1 | 2019 | 2050 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1262 | 0.020 |
Why?
|
Phagocytosis | 2 | 2006 | 1530 | 0.020 |
Why?
|
Zinc Fingers | 2 | 2004 | 577 | 0.020 |
Why?
|
Interleukin-1 | 2 | 2004 | 1252 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2001 | 3601 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2007 | 3096 | 0.020 |
Why?
|
Mutation | 2 | 2005 | 30214 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6009 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4414 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3669 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4937 | 0.020 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2008 | 44 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7067 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1761 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13289 | 0.020 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2008 | 92 | 0.020 |
Why?
|
Heart Rate | 1 | 2019 | 4215 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1998 | 3612 | 0.020 |
Why?
|
Thrombomodulin | 1 | 2007 | 107 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 13053 | 0.020 |
Why?
|
Carrageenan | 1 | 2006 | 71 | 0.020 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2008 | 330 | 0.020 |
Why?
|
Insulin | 1 | 2021 | 6606 | 0.020 |
Why?
|
Heart | 1 | 1998 | 4445 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2008 | 930 | 0.020 |
Why?
|
New Jersey | 1 | 2005 | 296 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2024 | 81748 | 0.020 |
Why?
|
Dinoprostone | 1 | 2008 | 597 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4426 | 0.010 |
Why?
|
Cardiac Tamponade | 1 | 2005 | 175 | 0.010 |
Why?
|
Sleep, REM | 1 | 1987 | 594 | 0.010 |
Why?
|
Medical Audit | 1 | 2005 | 454 | 0.010 |
Why?
|
Histone Acetyltransferases | 1 | 2006 | 335 | 0.010 |
Why?
|
HIV Reverse Transcriptase | 2 | 1996 | 214 | 0.010 |
Why?
|
HL-60 Cells | 1 | 2004 | 364 | 0.010 |
Why?
|
Macrophage-1 Antigen | 1 | 2004 | 286 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2004 | 424 | 0.010 |
Why?
|
Chemokines | 1 | 2008 | 963 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8539 | 0.010 |
Why?
|
Macaca mulatta | 2 | 2001 | 2364 | 0.010 |
Why?
|
Israel | 1 | 2005 | 726 | 0.010 |
Why?
|
Digoxin | 1 | 2004 | 246 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12464 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2004 | 826 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4210 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2004 | 668 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 102 | 0.010 |
Why?
|
Nuclear Matrix | 1 | 2002 | 30 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 2002 | 102 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 135 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2002 | 241 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2002 | 6515 | 0.010 |
Why?
|
Immunity | 1 | 2007 | 1004 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2001 | 151 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12795 | 0.010 |
Why?
|
Syncope | 1 | 2004 | 431 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 15831 | 0.010 |
Why?
|
Nausea | 1 | 2004 | 682 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6070 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 2 | 1998 | 2596 | 0.010 |
Why?
|
Vomiting | 1 | 2004 | 655 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2002 | 254 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 714 | 0.010 |
Why?
|
Mice, SCID | 1 | 2006 | 2627 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2007 | 1163 | 0.010 |
Why?
|
Viral Load | 2 | 2001 | 3396 | 0.010 |
Why?
|
Fibrinogen | 1 | 2004 | 892 | 0.010 |
Why?
|
HMGA1a Protein | 1 | 2001 | 63 | 0.010 |
Why?
|
Interferon Regulatory Factors | 1 | 2002 | 271 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 846 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2748 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2004 | 1494 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41753 | 0.010 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2001 | 293 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2002 | 616 | 0.010 |
Why?
|
HIV Infections | 2 | 1996 | 17569 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1989 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2005 | 1308 | 0.010 |
Why?
|
Leucine Zippers | 1 | 1998 | 116 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2005 | 1171 | 0.010 |
Why?
|
L-Selectin | 1 | 1998 | 212 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 1999 | 439 | 0.010 |
Why?
|
HeLa Cells | 1 | 2004 | 3074 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1998 | 420 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2001 | 827 | 0.010 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 1998 | 213 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 1998 | 564 | 0.010 |
Why?
|
Proviruses | 1 | 1998 | 319 | 0.010 |
Why?
|
Neutralization Tests | 1 | 1998 | 739 | 0.010 |
Why?
|
COS Cells | 1 | 1998 | 1135 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1998 | 866 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 2191 | 0.010 |
Why?
|
Zalcitabine | 1 | 1996 | 43 | 0.010 |
Why?
|
Myosin Heavy Chains | 1 | 1998 | 404 | 0.010 |
Why?
|
Didanosine | 1 | 1996 | 151 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2393 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3798 | 0.010 |
Why?
|
Adipocytes | 1 | 2002 | 1197 | 0.010 |
Why?
|
Adult | 3 | 2021 | 223577 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3284 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1996 | 301 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 1998 | 921 | 0.010 |
Why?
|
Depressive Disorder | 1 | 1987 | 3721 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1998 | 1892 | 0.010 |
Why?
|
Lamivudine | 1 | 1996 | 367 | 0.010 |
Why?
|
Cross Reactions | 1 | 1996 | 828 | 0.010 |
Why?
|
Collagen | 1 | 2001 | 2641 | 0.010 |
Why?
|
Viremia | 1 | 1996 | 726 | 0.010 |
Why?
|
Drug Resistance, Microbial | 1 | 1996 | 830 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1996 | 1162 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3448 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12075 | 0.010 |
Why?
|
Cholesterol | 1 | 2001 | 2914 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2001 | 2450 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2005 | 5349 | 0.010 |
Why?
|
Deoxycytidine | 1 | 1996 | 887 | 0.010 |
Why?
|
Virus Replication | 1 | 1998 | 2458 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1998 | 1816 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 1987 | 5130 | 0.010 |
Why?
|
Oligopeptides | 1 | 1996 | 1194 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8120 | 0.010 |
Why?
|
DNA, Viral | 1 | 1996 | 2201 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 13000 | 0.000 |
Why?
|
Coronary Angiography | 1 | 1999 | 4541 | 0.000 |
Why?
|
Echocardiography | 1 | 1999 | 5050 | 0.000 |
Why?
|
Survival Rate | 1 | 1999 | 12827 | 0.000 |
Why?
|
Antiviral Agents | 1 | 1996 | 3073 | 0.000 |
Why?
|
Reaction Time | 1 | 1987 | 2098 | 0.000 |
Why?
|
Prospective Studies | 1 | 2005 | 54921 | 0.000 |
Why?
|
Genetic Variation | 1 | 1996 | 6612 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1987 | 6029 | 0.000 |
Why?
|
Electroencephalography | 1 | 1987 | 6311 | 0.000 |
Why?
|